Two families with benign hyperphosphatasemia of intestinal origin were studied and compared with six other cases reported in the literature. No evidence of clinical abnormalities or explanations for the unusual enzyme concentrations were found. Agarose gel electrophoresis of alkaline phosphatase (ALP, EC 3.1.3.1) isoenzymes in serum demonstrated markedly increased intestinal isoforms (the "soluble" and the "hydrophobic"forms), which accounted for -60% of total ALP activity. The description of these families demonstrated patterns suggesting autosomal-dominant inheritance, even if the precise genetic background of the abnormality affecting the enzyme production or the control mechanisms for its entry into the circulation could not be determined. 
interval, 30-85 U/L). Two months later, his serum ALP was 645 U/L, and two years after the original observation was 483 U/L. Serum ALP five years after the initial presentation was persistently increased (320 UIL) in the absence of any associated illness. ALP isoenzyme analysis (see below) showed a tremendous increase in the intestinal fractions in all samples (46% to 60% of total ALP activity), and a systematic survey of the whole family showed an identical isoenzyme pattern in some family members (Figure 1) .
Case 2: OB, a 16-year-old asymptomatic boy (blood group A, Rh-), had a routine automated blood chemistry panel (SMAC II; Technicon, Tarrytown, NY) performed at a local laboratory. All results were within the reference limits, except for serum ALP, which was 542 U/L (age-related reference interval, 50-300 U/L). Measurement five months later confirmed that the concentration of serum ALP was persistently increased (393 U/L) and laboratory consultation was requested. Consequently, sera were obtained from the propositus, his parents, sister, and members of the immediate family, for enzyme and isoenzyme studies. Intestinal ALP activity was increased in many samples ( Figure 2 Figure 3 shows the isoenzyme patterns of the two cases studied. In both samples, I encountered a marked increase in the common intestinal fraction (in the 6-region of serum proteins) and the presence of a second fraction that co-migrated with bone ALP in the slowmoving a2-region, but it was less diffuse and neuraminidase-resistant ( Figure 3, lanes 2 and 7) . The change in electrophoretic mobility after incubation with the antiplacental/intestinal antiserum in association with the resistance toneuraminidase identified bothfractions as intestinal.
The additional fraction of intestinal-type isoenzyme corresponded to the intestinal 'variant" ALP described by Van Hoof et al. (10,16) inmost conditions where the main intestinal ALP was also present. Like intestinal ALP, this fraction showed a marked decrease in staining intensity when L-phenylalanine was incorporated inthe staining medium, whereas liver and bone ALP were minimally affected. Pretreatment with papain and bromelain (not shown) and withphospholipase C (Figure 4 )reduced the electrophoretic mobility of this fraction toexactly that of the common intestinal isoenzyme.
DIscussion
Persistent idiopathic increased ALP activity was first described in an American family by Wilson (17) , who reported increased activity of both liver and bone isoenzymes and an autosomal-dominant form of inheritance. 
